![Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology](https://www.futuremedicine.com/cms/10.2217/14796694.2.6.677/asset/images/medium/graphic15.gif)
Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology
![References in Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial - The References in Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial - The](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/aa07bba9-0f19-4783-bb5b-0b2033238ce9/gr1_lrg.gif)
References in Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial - The
![Is hormonal treatment still an option in acne today? - Bettoli - 2015 - British Journal of Dermatology - Wiley Online Library Is hormonal treatment still an option in acne today? - Bettoli - 2015 - British Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/52c282d0-3372-4376-990c-2100390658e5/bjd13681-fig-0003-m.jpg)
Is hormonal treatment still an option in acne today? - Bettoli - 2015 - British Journal of Dermatology - Wiley Online Library
![Cancers | Free Full-Text | Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope | HTML Cancers | Free Full-Text | Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope | HTML](https://www.mdpi.com/cancers/cancers-12-00051/article_deploy/html/images/cancers-12-00051-g001.png)
Cancers | Free Full-Text | Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope | HTML
![Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses | Semantic Scholar Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cf19da6ab421b4b20646793e2c2da5adfd76df2a/3-Figure1-1.png)
Gonadotropin-Releasing Hormone (GnRH) Agonist Implants for Male Dog Fertility Suppression: A Review of Mode of Action, Efficacy, Safety, and Uses | Semantic Scholar
![Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial - The Journal of Sexual Medicine Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial - The Journal of Sexual Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/81c0f98a-769e-43bf-9f21-a21db8beb664/gr1_lrg.jpg)
Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial - The Journal of Sexual Medicine
![Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-018-0079-0/MediaObjects/41391_2018_79_Fig1_HTML.png)
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
![Cyproterone acetate–‐mechanism of action and clinical effectiveness in prostate cancer treatment - Schröder - 1993 - Cancer - Wiley Online Library Cyproterone acetate–‐mechanism of action and clinical effectiveness in prostate cancer treatment - Schröder - 1993 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/dd001122-cdc0-4fc5-a443-ab9b4fad5676/1097-0142(19931215)72:12+%3C3810::aid-cncr2820721710%3E3.0.co;2-o.fp.png)